Privacy Policy | Cookie Policy
BIOTECHNOLOGY EVOLVED BY NATURE
*ABOUT EVE
EVE – The Biofactory
EVE – The Biofactory – is a spin-off of the Italian National Research Council (CNR) that created a pioneering platform for the production and engineering of Extracellular Vesicles (EVs) from a green, sustainable source: micro-algae. These EVs, which we have named algosomes, are produced through a scalable and GMP-compliant process, with the aim to develop new configurable therapeutic and cosmetic formulations.
*WHY EVE?
Advantages
The production of EVs is nowadays challenging from both an economical and technological perspective. The disruptive manufacturing process proposed by EVE – The Biofactory overcomes the limitations of standard processes offering unique advantages:
*GOALS
The road ahead
EVE’s mission is to bring to the market a new type of EVs called algosomes. These are produced from entirely photosynthetic (green) and renewable sources, providing companies with innovative products and enabling services for the development of revolutioning therapies and cosmetic formulations.
*TECHNOLOGY
EVE's scientific and technological background
EVE – The Biofactory has established a patented production process of algosomes from naturally growing microalgae, with high and controllable productivity dependent on a selection of producer species and microenvironment factors. The variability of the input material is minimised, granting high batch-to-batch consistency, and repeatedly yielding vesicles with stable biophysical and biochemical properties. Algosomes have the additional appeal of being natural and societally acceptable as green and renewable bioproducts. EVE is a spin off of the H2020-FET Open project VES4US and EVE biotechnologies are further exploited in the context of the H2020-FETProactive project BOW.
VES4US is a project funded by the FET-Open Call of the Horizon2020 Programme of the European Commission which goal is to develop a radically new platform for the efficient production and functionalisation of EVs.
BOW is a project funded by the H2020-FET Proactive Call of the H2020 programme of the European Commission. The main objective of BOW is to create hybrid magnetic nanoparticles with a membrane surface made from an extracellular vesicle.
*TEAM
Behind EVE
Antonella Bongiovanni
CEO & founder
Mauro Manno
CSO & co-founder
Paolo De Stefanis
VP business development & co-founder
Natasa Zarovni
CTO
Francesca Petrucci
COO
Paola Gargano
Biotechnologist
*PARTNERS
A multidisciplinary expertise
Our partners proudly share their expertise and experience in research and business to help EVE change the EV world.
Consiglio Nazionale delle Ricerche
CNR is the largest public research institution in Italy, the only one under the Research Ministry performing multidisciplinary activities.
Atlantic Technological University
ATU is an irish multi-campus technological university that combines academic and research excellence
Day One
D1 is an Innovation Studio that teams up with researchers to transform disruptive technologies into game changing solutions.